Search results
The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4 ...
May 11, 2022 · The Centers for Disease Control and Prevention (CDC) has created a comprehensive guide for pediatricians on the first U.S. dengue vaccine as well as the disease itself, as infections are expected to increase. The CDC recommends Dengvaxia vaccine from Sanofi Pasteur Inc. for children ages 9-16 years who live in endemic areas.
May 14, 2024 · Watch out for warning signs of severe dengue. Warning signs usually begin in the 24–48 hours after your fever has gone away. Immediately go to a local clinic or emergency room if you or a family member has any of the following signs and symptoms: Belly pain, tenderness. Vomiting (at least 3 times in 24 hours)
May 11, 2022 · Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1–4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral disease worldwide, with the greatest burden in tropical and sub-tropical regions. In the absence of effective prevention and control measures, dengue is projected to increase in both disease burden and geographic ...
Dengue is an infection caused by four closely related viruses, referred to as dengue virus types 1-4. These viruses are carried by certain mosquitos, and the bite of the mosquito leads to the infection in people. The four viruses are part of the flaviviridae family and are closely related to other viruses that are carried by ticks or mosquitos ...
Jan 19, 2022 · What Are the Possible Side Effects of the Dengue Vaccine? For children who HAVE already had dengue. The most common side effects include soreness, itchiness, or pain in the injection site, headaches, lack of energy, and general discomfort. These side effects are normal signs that the body is building protection, and the side effects should go ...
Mar 7, 2024 · Overall, CYD demonstrated superior efficacy and clinical benefit in seropositive versus seronegative vaccine recipients. There was also a trend of superior efficacy and beneficial vaccine effect in older children, and these effects were noted against any dengue caused by all DENV types as well as severe and hospitalized dengue.
